Immunic Inc.

NASDAQ: IMUX · Real-Time Price · USD
0.79
-0.03 (-3.72%)
At close: Jun 17, 2025, 12:15 PM

Immunic Revenue

Immunic reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Immunic generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
91
Market Cap
75.31M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.